The role of HLA-G for protection of human renal cell–carcinoma cells from immune-mediated lysis: implications for immunotherapies

作者: Jürgen Bukur , Barbara Seliger

DOI: 10.1016/S1044-579X(03)00026-9

关键词:

摘要: HLA-G as a non-classical MHC class I molecule exhibits limited tissue distribution and exerts multiple immune regulatory functions including the induction of tolerance. In addition, has been detected in some tumors different histology therefore may represent novel escape mechanism tumor cells. Despite immunogenicity renal cell carcinoma (RCC), outgrowth cells occurs which might be attributable to abrogation efficient anti-tumor responses. We here review potential role RCC immunology, expression pattern its functional consequences on A heterogenous constitutive interferon- inducible mRNA protein was found lines lesions, but not autologous normal kidney epithelium. transcription at high frequency primary lesions lines. Functional studies performed with alloreactive natural lymphokine activated killer well antigen-specific CD8 + T populations demonstrated that inhibits lysis by these effector cells, whereas − were recognized. Thus, aberrant participate evasion from immunosurveillance. © 2003 Elsevier Science Ltd. All rights reserved.

参考文章(43)
Luis Miguel Real, Teresa Cabrera, Antonia Collado, Pilar Jimenez, Angel Garcia, Francisco Ruiz‐Cabello, Federico Garrido, None, Expression of HLA G in human tumors is not a frequent event. International Journal of Cancer. ,vol. 81, pp. 512- 518 ,(1999) , 10.1002/(SICI)1097-0215(19990517)81:4<512::AID-IJC2>3.0.CO;2-O
R Marchal-Bras-Goncalves, N Rouas-Freiss, F Connan, J Choppin, J Dausset, E.D Carosella, M Kirszenbaum, J.-G Guillet, A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity. International Conference on New Trends in Clinical and Experimental Immunosuppression. ,vol. 33, pp. 2355- 2359 ,(2001) , 10.1016/S0041-1345(01)02020-6
S. Ugurel, U. Reinhold, W. Tilgen, HLA-G in Melanoma: A New Strategy to Escape from Immunosurveillance? Onkologie. ,vol. 25, pp. 129- 134 ,(2002) , 10.1159/000055222
S. H. Landis, T. Murray, S. Bolden, P. A. Wingo, Cancer statistics, 1998 CA: A Cancer Journal for Clinicians. ,vol. 48, pp. 6- 29 ,(1998) , 10.3322/CANJCLIN.48.1.6
Elizabeth L. Broghammer, Timothy L. Ratliff, Immunotherapy of urologic tumors: principles and progress. Urologic Oncology-seminars and Original Investigations. ,vol. 7, pp. 45- 56 ,(2002) , 10.1016/S1078-1439(01)00151-X
Michael Lahn, Paul Fisch, Gabriele K&ouml;hler, Regina Kunzmann, Iris Hentrich, Heike Jesuiter, Dirk Behringer, Birgit Muschal, Hendrik Veelken, Peter Kulmburg, David N. Ikl&eacute;, Albrecht Lindemann, Pro-Inflammatory and T Cell Inhibitory Cytokines Are Secreted at High Levels in Tumor Cell Cultures of Human Renal Cell Carcinoma European Urology. ,vol. 35, pp. 70- 80 ,(1999) , 10.1159/000019821
Ronald Bukowski, Patricia Rayman, Charles Tannenbaum, Tracy Bloom, James H. Finke, A. Michelle Ward, Eric D. Hsi, Peter E. Clark, Raymond Tubbs, Andrew C. Novick, Vladimir Kolenko, Lydia J. Worford, Neil H. Bander, Luis Molto, Robert G. Uzzo, Mechanisms of apoptosis in T cells from patients with renal cell carcinoma. Clinical Cancer Research. ,vol. 5, pp. 1219- 1229 ,(1999)
Benoît J Van den Eynde, Béatrice Gaugler, Michael Probst-Kepper, Lucienne Michaux, Olivier Devuyst, Francis Lorge, Patrick Weynants, Thierry Boon, None, A New Antigen Recognized by Cytolytic T Lymphocytes on a Human Kidney Tumor Results from Reverse Strand Transcription Journal of Experimental Medicine. ,vol. 190, pp. 1793- 1800 ,(1999) , 10.1084/JEM.190.12.1793
Frédérique-Anne Le Gal, Béatrice Riteau, Christine Sedlik, Iman Khalil-Daher, Catherine Menier, Jean Dausset, Jean-Gérard Guillet, Edgardo D. Carosella, Nathalie Rouas-Freiss, HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes International Immunology. ,vol. 11, pp. 1351- 1356 ,(1999) , 10.1093/INTIMM/11.8.1351
Hiroshi Nakagomi, Pavel Pisa, Eva K. Pisa, Yasuyoshi Yamamoto, Eva Halapi, Karin Backlin, Claes Juhlin, Rolf Kiessling, Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal cell carcinoma International Journal of Cancer. ,vol. 63, pp. 366- 371 ,(1995) , 10.1002/IJC.2910630311